Barclays’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Barclays’s Portfolio AMSGP Stock Details AMSGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-30,719	Closed	-$4.39M	–	6709
2015 Q4	$4.39M	Buy	+30,719	New	+$4.63M	0.01%	1412
2015 Q3	–	Sell	-15,008	Closed	-$2.09M	–	7270
2015 Q2	$2.09M	Buy	15,008 +5,601	+60%	+$745K	﹤0.01%	2190
2015 Q1	$1.17M	Buy	+9,407	New	+$1.12M	﹤0.01%	2830
2014 Q4	–	Sell	-18,370	Closed	-$1.95M	–	7825
2014 Q3	$1.95M	Buy	+18,370	New	+$1.98M	﹤0.01%	2688

Other funds holding AMSGP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Barclays's AMSGP Position: Q1 2016 in Review

Barclays sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q1 2016, closing a stake of 30,719 shares — an estimated $4.39M sold.

Barclays first reported a position in AMSGP in Q3 2014 and held it in 4 quarters. The position peaked at $4.39M in Q4 2015. 26 funds tracked by Wall St. Rank hold AMSGP as of Q1 2016.

Barclays reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q1 2016 after selling out during the quarter.
Barclays sold 30,719 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q1 2016, an estimated $4.39M.
Barclays first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q3 2014 and held it in 4 quarters.
Barclays's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $4.39M in Q4 2015.
26 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.